Loading
Latest filing published 22 Jun 2021 for Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.), €2,453.
No signal scores available.
Michael Pine has a single filing on record, published on 22 June 2021: an open-market purchase of €2,453 in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). One trade is not enough to describe a pattern. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration